Concepedia

Ovarian cancer: The prognostic value of the serum half-life of CA125 during induction chemotherapy

M.E.L. van der Burg, Frits B. Lammes, Wim L.J. van Putten, G. Stoter

Gynecologic Oncology · 1988 · 140 citations · 9 references

DOI

Concepts

References

9

A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer

Robert C. Bast, Thomas L. Klug, Elena St. John et al. · New England Journal of Medicine · 1983 · 2.2K citations

, , +8

Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour marker

Peter Canney, Michael Moore, P M Wilkinson et al. · British Journal of Cancer · 1984 · 319 citations

, , +16

Randomized trial comparing two combination chemotherapy regimens (CHAP-5 v CP) in advanced ovarian carcinoma.

J.P. Neijt, W W ten Bokkel Huinink, M E van der Burg et al. · Journal of Clinical Oncology · 1987 · 312 citations

, , +17

Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 125) associated with human epithelial ovarian carcinomas.

Thomas L. Klug, Robert C. Bast, Jonathan M. Niloff et al. · PubMed · 1984 · 304 citations

, , +16

RANDOMISED TRIAL COMPARING TWO COMBINATION CHEMOTHERAPY REGIMENS (HEXA-CAF VS CHAP-5) IN ADVANCED OVARIAN CARCINOMA

J.P. Neijt, M.E.L. van der Burg, R. Vriesendorp et al. · The Lancet · 1984 · 250 citations · Full text

, , +12